To support efforts to stem the Zika outbreak, the CDC Foundation announced a $1 million donation from the Pfizer Foundation in funding for the comprehensive Zika response. Additionally, in-kind donations of up to 170,000 doses of injectable reversible contraceptive product from Pfizer have been provided for the Zika Contraception Access Network (Z-CAN) in Puerto Rico. In addition to donations of products and funding from multiple partners, this donation will provide essential support against this growing health threat for women who choose to delay or avoid pregnancy.

As Zika virus continues its rapid spread throughout Puerto Rico and with mosquito season underway, the CDC Foundation announced today that the Zika Contraception Access Network (Z-CAN) is now operational. The Network is providing women in Puerto Rico with a full range of contraceptive options free of charge on the same day of their healthcare service. 

A new communications campaign aimed at empowering pregnant women on how to prevent Zika virus transmission has launched in Puerto Rico. The campaign, part of an effort with the Centers for Disease Control and Prevention (CDC), the CDC Foundation, the Puerto Rico Department of Health and other partners announced in May, also focuses on empowering the social networks surrounding pregnant women—including partners, families, neighbors and community members—to take action to #StopZika in their homes and communities. 

The CDC Foundation announced a collaboration with the Centers for Disease Control and Prevention (CDC) and multiple organizations, including Allergan, Medicines360, Upstream USA and Merck, known as MSD outside the United States and Canada, to provide a range of contraceptive options to women in Puerto Rico.

In response to the growing Zika virus health threat, Bayer today committed to supporting two critical aspects of the Zika response in Puerto Rico: providing women and their partners who want to delay or avoid pregnancy during the Zika outbreak with improved access to a range of contraceptive methods and giving additional protection to families who want to sleep under mosquito-repelling bed nets. 

Educating communities and empowering women on how to prevent Zika virus transmission is the focus of a new collaborative effort by the Centers for Disease Control and Prevention (CDC), the Pan American Health Organization (PAHO) and the CDC Foundation, aimed mainly at pregnant women in U.S. territories and the Americas. 

The CDC Foundation today announced a partnership with CDC and multiple donors to create Zika prevention kits for pregnant women in the U.S. territories of Puerto Rico, the U.S. Virgin Islands and American Samoa.

As the Zika virus continues to spread quickly through many countries in the Americas, the U.S. Centers for Disease Control and Prevention (CDC) is accelerating its response to combat this health threat. At CDC’s request, the CDC Foundation has activated two funds: the U.S. Emergency Response Fund and the Global Disaster Response Fund. 

The CDC Foundation is partnering with the U.S. Centers for Disease Control and Prevention’s (CDC) Division of Blood Disorders within the National Center on Birth Defects and Developmental Disabilities, the California Rare Disease Surveillance Program (a project of the Public Health Institute, located in Oakland, CA) and Pfizer Inc. to support the development and implementation of a longitudinal data collection system for Americans with sickle cell disease.

To build capacity for population-based surveillance among individuals with a recent stillbirth within the United States.